MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+7.45%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$17.4B
AUM Growth
+$604M
(+3.6%)
Cap. Flow
-$359M
Cap. Flow
% of AUM
-2.06%
Top 10 Holdings %
Top 10 Hldgs %
29.23%
Holding
2,954
New
46
Increased
346
Reduced
1,409
Closed
76
Top Buys
| 1 |
Apple
AAPL
|
+$19.3M |
| 2 |
Palantir
PLTR
|
+$18.1M |
| 3 |
Avantor
AVTR
|
+$8.78M |
| 4 |
Dell
DELL
|
+$8.32M |
| 5 |
Broadcom
AVGO
|
+$6.78M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$43.9M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$25.3M |
| 3 |
NVIDIA
NVDA
|
+$25.3M |
| 4 |
Microsoft
MSFT
|
+$24.1M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$12.3M |
Sector Composition
| 1 | Technology | 29.87% |
| 2 | Financials | 12.38% |
| 3 | Healthcare | 11.43% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALX
2026
Alexander's
ALX
$1.22B
| $320K | ﹤0.01% |
1,321
-107
| -7% | -$25.9K |
|
2027
Scholar Rock
SRRK
$3B
| $320K | ﹤0.01% |
39,966
| – | – |
|
2028
Amalgamated Financial
AMAL
$857M
| $319K | ﹤0.01% |
10,183
-225
| -2% | -$7.06K |
|
2029
York Water
YORW
$440M
| $319K | ﹤0.01% |
8,524
| – | – |
|
2030
Willdan Group
WLDN
$1.48B
| $319K | ﹤0.01% |
7,793
| – | – |
|
2031
Arcturus Therapeutics
ARCT
$489M
| $318K | ﹤0.01% |
13,721
| – | – |
|
2032
Astronics
ATRO
$1.55B
| $318K | ﹤0.01% |
16,339
| – | – |
|
2033
Confluent
CFLT
$6.9B
| $318K | ﹤0.01% |
15,606
+70
| +0.5% | +$1.43K |
|
|
HTB
2034
HomeTrust Bancshares, Inc.
HTB
$718M
| $317K | ﹤0.01% |
9,305
| – | – |
|
2035
GigaCloud Technology
GCT
$1.06B
| $317K | ﹤0.01% |
13,784
+7,767
| +129% | +$178K |
|
2036
Thryv Holdings
THRY
$551M
| $316K | ﹤0.01% |
18,341
| – | – |
|
2037
MediaAlpha
MAX
$692M
| $316K | ﹤0.01% |
17,446
+3,906
| +29% | +$70.7K |
|
2038
Ultragenyx Pharmaceutical
RARE
$3.02B
| $316K | ﹤0.01% |
5,681
+73
| +1% | +$4.06K |
|
2039
Real Brokerage
REAX
$1.05B
| $315K | ﹤0.01% |
56,801
+32,005
| +129% | +$178K |
|
|
DEC
2040
Diversified Energy
DEC
$1.22B
| $315K | ﹤0.01% |
27,670
+15,591
| +129% | +$177K |
|
2041
Arbutus Biopharma
ABUS
$886M
| $315K | ﹤0.01% |
81,711
| – | – |
|
2042
4D Molecular Therapeutics
FDMT
$324M
| $314K | ﹤0.01% |
29,083
| – | – |
|
2043
Washington Trust Bancorp
WASH
$570M
| $314K | ﹤0.01% |
9,734
| – | – |
|
2044
ChargePoint
CHPT
$235M
| $313K | ﹤0.01% |
11,440
+6,446
| +129% | +$177K |
|
2045
Evolv Technologies
EVLV
$1.37B
| $312K | ﹤0.01% |
77,055
+5,090
| +7% | +$20.6K |
|
2046
Rayonier Advanced Materials
RYAM
$402M
| $312K | ﹤0.01% |
36,438
| – | – |
|
2047
GeneDx Holdings
WGS
$3.54B
| $310K | ﹤0.01% |
+7,297
| New | +$310K |
|
|
PKST
2048
Peakstone Realty Trust
PKST
$485M
| $309K | ﹤0.01% |
22,698
-5
| -0% | -$68 |
|
2049
Applied Optoelectronics
AAOI
$1.73B
| $309K | ﹤0.01% |
21,565
+12,151
| +129% | +$174K |
|
2050
HarborOne Bancorp
HONE
$551M
| $308K | ﹤0.01% |
23,757
| – | – |
|